ofost
as grindeks - oksitocinas - injekcinis ar infuzinis tirpalas - 10 tv/ml - oxytocin
efmody
diurnal europe b.v. - hidrokortizonas - adrenal hyperplasia, congenital - kortikosteroidų sisteminis naudoti - treatment of congenital adrenal hyperplasia (cah) in adolescents aged 12 years and over and adults.
cefazolin pharmsol
pharmsol europe limited - cefazolinas - milteliai injekciniam ar infuziniam tirpalui - 1000 mg - cefazolin
ephedrine hydrochloride sintetica
sintetica gmbh - efedrino hidrochloridas - injekcinis tirpalas - 10 mg/ml - ephedrine
ephedrine hydrochloride sintetica
sintetica gmbh - efedrino hidrochloridas - injekcinis tirpalas - 50 mg/ml - ephedrine
dexamethasone kalceks
as kalceks - deksametazono natrio fosfatas - injekcinis ar infuzinis tirpalas - 4 mg/ml - dexamethasone
brontex [ambroxol hydrochloride ratiopharm]
ratiopharm gmbh - ambroksolio hidrochloridas - šnypščiosios tabletės - 60 mg - ambroxol
dexamethasone phosphate medochemie
medochemie ltd. - deksametazono natrio fosfatas - injekcinis ar infuzinis tirpalas - 4 mg/ml - dexamethasone
abrysvo
pfizer europe ma eeig - respiratory syncytial virus, subgroup a, stabilized prefusion f protein / respiratory syncytial virus, subgroup b, stabilized prefusion f protein - respiraciniu sincitijaus infekcijos - vakcinos - abrysvo is indicated for:passive protection against lower respiratory tract disease caused by respiratory syncytial virus (rsv) in infants from birth through 6 months of age following maternal immunisation during pregnancy. Žr. 4 skyrius. 2 ir 5. active immunisation of individuals 60 years of age and older for the prevention of lower respiratory tract disease caused by rsv. naudoti šios vakcinos turėtų būti laikantis oficialių rekomendacijų.
sentoba
pharmaswiss Česká republika s.r.o. - bozentanas - plėvele dengtos tabletės - 62,5 mg; 125 mg - bosentan